References
- ShahPL, HerthFJ, van GeffenWH, DesleeG, SlebosDJ. Lung volume reduction for emphysema. Lancet Respir Med. 2017;5(2):147–156. doi:10.1016/S2213-2600(16)30221-127693408
- ScheibeN, SosnowskiN, PinkhasikA, VonderbankS, BastianA. Sonographic evaluation of diaphragmatic dysfunction in COPD patients. Int J Chron Obstruct Pulmon Dis. 2015;10:1925–1930. doi:10.2147/COPD.S8565926392767
- MathersCD, LoncarD. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. doi:10.1371/journal.pmed.003044217132052
- CasanovaC, CoteC, de TorresJP, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(6):591–597. doi:10.1164/rccm.200407-867OC15591470
- GompelmannD, EberhardtR, SlebosDJ, et al. Diagnostic performance comparison of the Chartis system and high-resolution computerized tomography fissure analysis for planning endoscopic lung volume reduction. Respirology. 2014;19(4):524–530. doi:10.1111/resp.1225324612306
- HerthFJ, NoppenM, ValipourA, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort: results from the International VENT Study Group. Eur Respir J. 2012;39(6):1334–1342. doi:10.1183/09031936.0016161122282552
- ValipourA, SlebosDJ, HerthF, et al. Endobronchial valve therapy in patients with homogeneous emphysema: results from the IMPACT study. Am J Respir Crit Care Med. 2016;194(9):1073–1082. doi:10.1164/rccm.201607-1383OC27580428
- SciurbaFC, ErnstA, HerthFJ, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363(13):1233–1244. doi:10.1056/NEJMoa090092820860505
- DaveyC, ZoumutZ, JordanS, et al. Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): a randomized controlled trial. Lancet. 2015;386(9998):1066–1073. doi:10.1016/S0140-6736(15)60001-026116485
- KloosterK, Ten HackenNH, HartmanJE, KerstjensHA, van RikxoortEM, SlebosDJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373(24):2325–2335. doi:10.1056/NEJMoa150780726650153
- SlebosDJ, ShahPL, HerthFJ, ValipourA. Endobronchial valves for endoscopic lung volume reduction: best practice recommendations from expert panel on endoscopic lung volume reduction. Respiration. 2017;93:138–150. doi:10.1159/00045358827992862
- SchuhmannM, RaffyP, YinY, et al. Computed tomography predictors of response to endobronchial valve lung reduction treatment: comparison with Chartis. Am J Respir Crit Care Med. 2015;191(7):767–774. doi:10.1164/rccm.201407-1205OC25635349
- KosterTD, van RikxoortEM, HuebnerRH, et al. Predicting lung volume reduction after endobronchial valve therapy is maximized using a combination of diagnostic tools. Respiration. 2016;92:150–157. doi:10.1159/00044884927577190
- ArgulaRG, StrangeC, RamakrishnanV, GoldinJ. Baseline regional perfusion impacts exercise response to endobronchial valve therapy in advanced pulmonary emphysema. Chest. 2013;144:1578–1586. doi:10.1378/chest.12-282623828481
- ThomsenC, TheiligD, HerzogD, et al. Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy. Int J Chron Obstruct Pulmon Dis. 2016;11:1245–1259. doi:10.2147/COPD.S10100327354783
- OttenheijmCA, HeunksLM, SieckGC, et al. Diaphragm dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;172(2):200–205. doi:10.1164/rccm.200502-262OC15849324
- WangY, LaiTW, XuF, et al. Efficacy and safety of bronchoscopic lung volume reduction therapy in patients with severe emphysema: a meta-analysis of randomized controlled trials. Oncotarget. 2017;8(44):78031–78043. doi:10.18632/oncotarget.1935229100445
- van GeffenWH, SlebosDJ, HerthFJ, KempSV, WederW, ShahPL. Surgical and endoscopic interventions that reduce lung volume for emphysema: a systemic review and meta-analysis. Lancet Respir Med. 2019;7(4):313–324. doi:10.1016/S2213-2600(18)30431-430744937
- KempSV, SlebosD-J, KirkA, et al. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med. 2017;196(12):1535–1543. doi:10.1164/rccm.201707-1327OC28885054